Lee Revised Cardiac Risk Index
The Lee Revised Cardiac Risk Index estimates the likelihood of major cardiac complications after noncardiac surgery based on six clinical predictors.
Indications for Use
Used to estimate perioperative MACE risk in elective, urgent, or time‑sensitive noncardiac surgery in stable adults to determine if overall risk is <1% vs ≥1% and whether further testing or optimization is needed 1. Most reliable in mixed noncardiac surgery and less accurate in vascular surgery 2. Not validated for emergent surgery. Clinical utility is rapid stratification to guide need for additional evaluation or perioperative management.
Insights & Cautions
Identifies cardiac event risk reasonably but often underestimates risk in vascular and valvular disease 1 [Level II evidence]. Does not assess stroke, bleeding, ICU need, or hospitalization length. Misclassifies low‑risk patients in ~25–30% of cases in pooled validation studies 2 [Level I evidence]. Use as one input—not a standalone decision tool in modern guidelines.